688336.SHG Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
34.17 CNY
Close of Nov 5, 2026
30.65 65.85
Market cap
CNY 30.6B
P/E
9.9x
P/B
3.19x
ROE
9.0%
Dividend yield
0.25%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688336.SHG undervalued?

Graham number
Price34.17
Graham value28.77
Premium18.7%

688336.SHG trades 18.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sunshine Guojian Pharmaceutical Shanghai Co Ltd fundamental analysis

No fundamental analysis for Sunshine Guojian Pharmaceutical Shanghai Co Ltd yet.

Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include Enbrel, a recombinant human type II tumor necrosis factor receptor-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation; and Enbrel…

Full company profile